{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:01Z","timestamp":1707524521364},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,22]]},"DOI":"10.7759\/cureus.23398","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T17:27:25Z","timestamp":1647970045000},"source":"Crossref","is-referenced-by-count":1,"title":["Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein"],"prefix":"10.7759","author":[{"given":"Bryce R","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J","family":"Rendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley W","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent J","family":"Huddleston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua L","family":"Fenderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007090981","article-title":"PTH-related peptide (PTHrP) in hypercalcemia","volume":"19","author":"Mundy GR","year":"2008","unstructured":"Mundy GR, Edwards JR. PTH-related peptide (PTHrP) in hypercalcemia. J Am Soc Nephrol. 2008, 19:672-5. 10.1681\/ASN.2007090981","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: causes and survival in 138 patients","volume":"100","author":"Donovan PJ","year":"2015","unstructured":"Donovan PJ, Achong N, Griffin K, Galligan J, Pretorius CJ, McLeod DS. PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab. 2015, 100:2024-9. 10.1210\/jc.2014-4250","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000181252","article-title":"Humoral hypercalcemia of malignancy","volume":"32","author":"Martin TJ","year":"1989","unstructured":"Martin TJ. Humoral hypercalcemia of malignancy. Horm Res. 1989, 32:84-8. 10.1159\/000181252","journal-title":"Horm Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/1040-8428(91)90015-5","article-title":"Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment","volume":"11","author":"Mosekilde L","year":"1991","unstructured":"Mosekilde L, Eriksen EF, Charles P. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment. Crit Rev Oncol Hematol. 1991, 11:1-27. 10.1016\/1040-8428(91)90015-5","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1564::AID-CNCR6>3.0.CO;2-K","article-title":"Parathyroid hormone-related protein and hypercalcemia","volume":"80","author":"Rankin W","year":"1997","unstructured":"Rankin W, Grill V, Martin TJ. Parathyroid hormone-related protein and hypercalcemia. Cancer. 1997, 80:1564-71. 10.1002\/(SICI)1097-0142(19971015)80:8+&lt;1564::AID-CNCR6&gt;3.0.CO;2-K","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90220-W","article-title":"Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia","volume":"339","author":"Ratcliffe WA","year":"1992","unstructured":"Ratcliffe WA, Hutchesson AC, Bundred NJ, Ratcliffe JG. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia. Lancet. 1992, 339:164-7. 10.1016\/0140-6736(92)90220-W","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2014.042","article-title":"Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D","volume":"5","author":"Zhu V","year":"2014","unstructured":"Zhu V, de Las Morenas A, Janicek M, Hartshorn K. Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D. J Gastrointest Oncol. 2014, 5:E84-7. 10.3978\/j.issn.2078-6891.2014.042","journal-title":"J Gastrointest Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/136518201753242253","article-title":"Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia","volume":"3","author":"Papazachariou IM","year":"2001","unstructured":"Papazachariou IM, Virlos IT, Williamson RC. Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia. HPB (Oxford). 2001, 3:221-5. 10.1080\/136518201753242253","journal-title":"HPB (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner W","year":"2016","unstructured":"Goldner W. Cancer-related hypercalcemia. J Oncol Pract. 2016, 12:426-32. 10.1200\/JOP.2016.011155","journal-title":"J Oncol Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1700\/1636.17936","article-title":"Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour","volume":"100","author":"Rossi RE","year":"2014","unstructured":"Rossi RE, Naik K, Navalkissoor S, Imber C, O'Beirne J, Toumpanakis C, Caplin ME. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour. Tumori. 2014, 100:153e-6e. 10.1700\/1636.17936","journal-title":"Tumori"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000291","article-title":"Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor","volume":"61","author":"Valdes-Socin H","year":"2017","unstructured":"Valdes-Socin H, Almanza MR, Fern\u00e1ndez-Ladreda MT, Daele DV, Polus M, Chavez M, Beckers A. Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor. Arch Endocrinol Metab. 2017, 61:506-9. 10.1590\/2359-3997000000291","journal-title":"Arch Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020773","article-title":"Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers","volume":"88","author":"Horwitz MJ","year":"2003","unstructured":"Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Oca\u00f1a A, Stewart AF. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab. 2003, 88:1603-9. 10.1210\/jc.2002-020773","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","article-title":"Hypercalcemia of malignancy","volume":"9","author":"Feldenzer KL","year":"2018","unstructured":"Feldenzer KL, Sarno J. Hypercalcemia of malignancy. J Adv Pract Oncol. 2018, 9:496-504.","journal-title":"J Adv Pract Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84872-neuroendocrine-carcinoma-as-a-cause-of-humoral-hypercalcemia-of-malignancy-a-case-of-a-patient-with-elevated-parathyroid-hormone-related-protein","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:21Z","timestamp":1707507741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84872-neuroendocrine-carcinoma-as-a-cause-of-humoral-hypercalcemia-of-malignancy-a-case-of-a-patient-with-elevated-parathyroid-hormone-related-protein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.23398","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}